Latest filing published 19 Mar 2024 for Stoke Therapeutics, Inc., €23k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +49.0%Entry US$5.00 · Close at T+365 US$7.45
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen J. Tulipano: trading record in brief
Filings by Stephen J. Tulipano span 3 companies, the busiest being Stoke Therapeutics, Inc., Javelin Pharmaceuticals, Inc and Aldeyra Therapeutics, Inc. We count 28 filings; the first trade dates from 1 May 2009 and the latest from 19 March 2024.
The open-market side counts 1 purchase for €14k alongside 13 sales for €3.8M. The net balance comes to €3.8M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 share grants and 7 option exercises. 2024 to date brings no purchases and 1 sale.
On 19 March 2024 came the latest disclosure, an open-market sale for €23k in Stoke Therapeutics, Inc. The last insider purchase was made public on 21 February 2017, 3,547 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen J. Tulipano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,116 shares@ US$6.100.5% of flowCommon StockSEC:0001415889-24-008690:1
- 13,100 shares0Common StockSEC:0001415889-24-008690:0
- 11,160 shares@ US$4.48100.0% of flowCommon StockSEC:0001209191-22-034170:0
- 25,000 shares@ US$4.482.2% of flowCommon StockSEC:0001209191-21-013897:0
- 15,202 shares@ US$58.6717.5% of flowCommon StockSEC:0001209191-21-013897:1
- 9,696 shares@ US$59.2911.3% of flowCommon StockSEC:0001209191-21-013897:2
- 102 shares@ US$60.000.1% of flowCommon StockSEC:0001209191-21-013897:3
- 5,000 shares@ US$4.480.4% of flowCommon StockSEC:0001209191-21-013897:4
- 5,000 shares@ US$58.605.7% of flowCommon StockSEC:0001209191-21-013897:5
- 35,000 shares@ US$4.485.1% of flowCommon StockSEC:0001209191-20-056953:0
- 20,155 shares@ US$36.787324.1% of flowCommon StockSEC:0001209191-20-056953:1
- 14,445 shares@ US$37.861517.7% of flowCommon StockSEC:0001209191-20-056953:2
- 400 shares@ US$38.4350.5% of flowCommon StockSEC:0001209191-20-056953:3
- 1,732 shares@ US$4.480.3% of flowCommon StockSEC:0001209191-20-056953:4
- 1,732 shares@ US$39.83692.2% of flowCommon StockSEC:0001209191-20-056953:5
- 33,268 shares@ US$4.484.8% of flowCommon StockSEC:0001209191-20-056953:6
- 16,941 shares@ US$40.026321.8% of flowCommon StockSEC:0001209191-20-056953:7
- 11,111 shares@ US$41.419714.8% of flowCommon StockSEC:0001209191-20-056953:8
- 5,216 shares@ US$41.96897.0% of flowCommon StockSEC:0001209191-20-056953:9
- 2,077 shares@ US$3.9522.6% of flowCommon StockSEC:0000899243-18-006817:0
- 3,153 shares@ US$4.0033.2% of flowCommon StockSEC:0000899243-18-006817:1
- 3,333 shares@ US$4.5044.2% of flowCommon StockSEC:0000899243-17-004750:0Canonical exit: 18 May 2017 (T+90)
- 10,115 shares@ US$2.20Common StockSEC:0001209191-10-036961:0
- 12,500 shares@ US$2.20Restricted Stock UnitsSEC:0001209191-10-036961:1
- 2,385 shares@ US$2.18Common Stock, par value $0.001SEC:0000950117-10-000544:0
25 of 28 declarations
